Cell cycle, CDKs and cancer: a changing paradigm
- PMID: 19238148
- DOI: 10.1038/nrc2602
Cell cycle, CDKs and cancer: a changing paradigm
Abstract
Tumour-associated cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity. Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability. According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively _target tumour cells. However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells. Emerging evidence suggests that tumour cells may also require specific interphase CDKs for proliferation. Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.
Trial registration: ClinicalTrials.gov NCT00141297 NCT00147485 NCT00292864 NCT00372073 NCT00390117 NCT00400296 NCT00407498 NCT00446342 NCT00772876.
Similar articles
-
Cyclins and CDKS in development and cancer: lessons from genetically modified mice.Front Biosci. 2006 Jan 1;11:1164-88. doi: 10.2741/1871. Front Biosci. 2006. PMID: 16146805 Review.
-
Revisiting the "Cdk-centric" view of the mammalian cell cycle.Cell Cycle. 2005 Feb;4(2):206-10. doi: 10.4161/cc.4.2.1406. Epub 2005 Feb 3. Cell Cycle. 2005. PMID: 15655365
-
[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].Cancer Radiother. 2001 Apr;5(2):109-29. doi: 10.1016/s1278-3218(01)00087-7. Cancer Radiother. 2001. PMID: 11355576 Review. French.
-
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.Pharmacol Res. 2019 Jan;139:471-488. doi: 10.1016/j.phrs.2018.11.035. Epub 2018 Nov 30. Pharmacol Res. 2019. PMID: 30508677 Review.
-
Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.Methods Mol Biol. 2016;1336:155-66. doi: 10.1007/978-1-4939-2926-9_13. Methods Mol Biol. 2016. PMID: 26231715
Cited by
-
Automated workflow for the cell cycle analysis of (non-)adherent cells using a machine learning approach.Elife. 2024 Nov 22;13:RP94689. doi: 10.7554/eLife.94689. Elife. 2024. PMID: 39576677 Free PMC article.
-
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitors.Acta Pharmacol Sin. 2024 Nov 20. doi: 10.1038/s41401-024-01422-5. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39567751
-
Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation.Sci Rep. 2024 Nov 20;14(1):28794. doi: 10.1038/s41598-024-80455-6. Sci Rep. 2024. PMID: 39567714 Free PMC article.
-
Bioinformatics Analysis Reveals CDK1 and DLGAP5 as Key Modulators of Tumor Immune Cell Infiltration in Hepatocellular Carcinoma.Cancer Manag Res. 2024 Nov 14;16:1597-1608. doi: 10.2147/CMAR.S478426. eCollection 2024. Cancer Manag Res. 2024. PMID: 39559249 Free PMC article.
-
Construction of a novel lipid drop-mitochondria-associated genetic profile for predicting the survival and prognosis of lung adenocarcinoma.Discov Oncol. 2024 Nov 17;15(1):668. doi: 10.1007/s12672-024-01526-8. Discov Oncol. 2024. PMID: 39551861 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous